In December 2013, Sanofi opened its submissions for the second challenge in its Partners in Patient Health
In December 2013, Sanofi opened its submissions for the second challenge in its Partners in Patient Health, which is an open innovation challenge to "embrace a novel approach to partnering with people, ideas, and solutions across the advocacy community." The goal is to focus on critical issues that will advance patient and consumer health, while offering new solutions to improve the drug development process. This year, the focus was on Collaborate Innovate and teams of non-profit patient, provider or professional associations that collaborated on their initiatives and submissions.
The finalist event will take place at Sanofi's U.S. Headquarters in Bridgewater, NJ on May 9. the finalists will present their refined solutions and implementation plans to the judges at the finalist event, and the winning team will receive $100,000 and the opportunity to access additional expertise and non-monetary resources through Sanofi US.
The four finalists to this challenge were announced last month, and include:
Combating Muscle Loss
Capturing patient voice on muscle loss and impact on quality of life to improve recognition of sarcopenia. Insights from a simple survey for older patients will assist pharma, researchers, and regulatory to develop treatments, while a new function on aginginmotion.org will encourage patients to learn about emerging research and clinical trials.
Partnering Organizations: Alliance for Aging Research, University of Maryland School of Medicine
Glu Real-World Research App
A living laboratory for type 1 diabetes research inside an app. Patient data and interaction from the Glu app will drive research creation, preclinical ideas, patient engagement and education, and co-creation of activities.
Partnering Organizations: T1D Exchange/Unitio, Inc., MIT Hacking Medicine
Medical Heroes Science Exhibit
A unique traveling museum exhibit dedicated to recognizing the gift of volunteer participation in clinical research. A first of its kind, the 12-city, 3-year exhibit tour targets children through high schoolers and their families. The aim of the exhibit is to change public perception, and build appreciation and support of clinical trials by showcasing volunteers’ experiences, engaging visitors in interactive educational activities, and connecting research participation to advancements in public health.
Partnering Organizations: The Center for Information and Study on Clinical Research Participation (CISCRP), Association of Clinical Research Professionals (ACRP), Association of Clinical Research Organizations (ACRO)
Veterans Advancing ALS/MND
“Big data” genetic analysis to provide new clues to the higher incidence of ALS in veterans. Connecting open innovation, reliable veterans organizations, and the ALS research community aims to provide new conclusive insights about ALS and accelerate application of individualized therapies.
Partnering Organizations: Innovative Solutions Consortium, Johns Hopkins University
View more info at www.collaborateinnovate.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.